Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.

PHASE2RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Patellofemoral Osteoarthritis
Interventions
BIOLOGICAL

N-TEC

Implantation of an autologous tissue engineered cartilage graft in the patellofemoral joint for treatment of osteoarthritis.

BIOLOGICAL

Platelet rich plasma

"Injection of an autologous Conditioned Plasma ACP® on the basis of one injection per week for three consecutive weeks.~Conditioned Plasma ACP®, Arthrex, one injection per week for three consecutive weeks."

Trial Locations (9)

1205

RECRUITING

Hôpitaux universitaires de Genève, Geneva

3010

NOT_YET_RECRUITING

Inselspital, Bern

4031

RECRUITING

University Hospital Basel, Basel

4054

RECRUITING

Crossklinik, Basel

6962

RECRUITING

Ospedale Regionale di Lugano, Lugano

8032

RECRUITING

Sportclinic, Klinik Hirslanden, Zurich

10000

RECRUITING

Poliklinika Ivković, Zagreb

79106

NOT_YET_RECRUITING

Universitätsklinikum Freiburg, Freiburg im Breisgau

97074

NOT_YET_RECRUITING

Orthopädische Klinik König-Ludwig-Haus, Würzburg

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Clinical Trial Unit, University Hospital Basel, Switzerland

OTHER

collaborator

University Hospital Wurzburg

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER